Clinical Trial Update: Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluate safety, tolerability, and efficacy of zilucoplan in generalized myasthenia gravis; the study is completed and results have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis Generalized

Drugs mentioned

• Zilucoplan (zilucoplan)

Snippet

Sponsor: Ra Pharmaceuticals, Inc. | Conditions: Myasthenia Gravis, Generalized | Phase 3 | Status: COMPLETED | Results posted: 2023-01-17